ADVERTISEMENT
Sentinel Lymph Node Biopsy Without Systematic Pelvic Lymphadenectomy is Safe, Effective for Patients With Early-Stage Cervical Cancer
At the Society of Gynecological Oncology (SGO) 2024 Annual Meeting, David Cibula, MD, PhD, General University Hospital, Prague, Czech Republic, discussed results from the CEEGOG CX-01, ENGOT-CX2 trial. Results identified sentinel lymph node biopsy plus pathologic ultrastaging as a safe and effective method of detecting lymph node metastases among patients with early-stage cervical cancer.
Source:
Marnitz S, Klat J, Jarkovsky J, et al. Survival of patients with early-stage cervical cancer after SLN biopsy without systematic pelvic lymphadenectomy: Primary endpoint outcome of the SENTIX prospective, single-arm, international trial (CEEGOG CX-01; ENGOT-CX2). Presented at the SGO 2024 Annual Meeting; March 16-18, 2024; San Diego, California